With Soriot out, Roche taps O'Day to lead pharma business

Roche ($RHHBY) pharma chief Pascal Soriot's departure for AstraZeneca ($AZN) triggered a bit of musical chairs at the Swiss drugmaker. Daniel O'Day, who's been COO of Roche Diagnostics, will take the helm at Roche Pharma, and Roland Diggelmann will move up to take O'Day's place. Release | Report

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.